MedTrace Logo

Centralization and Oncologic Outcomes in Ovarian Cancer

NCT07075939 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-07-20

No results posted yet for this study

Summary

This is a multicenter, observational, retrospective and prospective study conducted within the REMO (Reggio Emilia - Modena) network in the Emilia-Romagna region (Italy), promoted by AUSL-IRCCS of Reggio Emilia.

The study aims to evaluate the impact of surgical centralization and treatment strategies adopted during the COVID-19 pandemic on oncologic outcomes in patients diagnosed with the epithelial ovarian cancer (EOC) from 2018 to 2023.

The retrospective component includes patients treated between 2018 and 2023, while the prospective component consists of clinical follow-up of those patients over the next five years.

Conditions

  • Epithelial Ovarian Cancer
  • Ovarian Neoplasms
  • Advanced Ovarian Cancer

Interventions

OTHER

No Intervention: Observational Cohort

Observational data collection only

Sponsors & Collaborators

  • AUSL di Modena - Ospedale Ramazzini di Carpi

    collaborator UNKNOWN

  • AUSL di Modena - Ospedale di Mirandola

    collaborator UNKNOWN

  • AUSL di Modena - Ospedale Civile di Sassuolo

    collaborator UNKNOWN

  • AUSL di Modena - Ospedale di Pavullo nel Frignano

    collaborator UNKNOWN

  • AUSL di Modena - Ospedale di Vignola

    collaborator UNKNOWN

  • Azienda Ospedaliero-Universitaria di Modena

    collaborator OTHER

  • Azienda USL Reggio Emilia - IRCCS

    lead OTHER_GOV

Principal Investigators

  • Vincenzo Dario Mandato, MD · Azienda USL - IRCCS di Reggio Emilia

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-27
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07075939 on ClinicalTrials.gov